KA
ABMD

Kovack Advisors’s Abiomed Inc ABMD Stock Holding History

Kovack Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-720
Closed -$234K – 490
2018
Q4 		$234K Hold
720
– – 0.07% 315
2018
Q3 		$324K Sell
720
-356
-33% -$140K 0.08% 281
2018
Q2 		$440K Buy
1,076
+336
+45% +$122K 0.12% 197
2018
Q1 		$215K Buy
+740
New +$188K 0.05% 408

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Kovack Advisors's ABMD Position: Q1 2019 in Review

Kovack Advisors sold out of Abiomed Inc (ABMD) in Q1 2019, closing a stake of 720 shares — an estimated $234K sold.

Kovack Advisors first reported a position in ABMD in Q1 2018 and held it in 4 quarters. The position peaked at $440K in Q2 2018. 559 funds tracked by Wall St. Rank hold ABMD as of Q1 2019.

  • Kovack Advisors reported no remaining Abiomed Inc position as of Q1 2019 after selling out during the quarter.
  • Kovack Advisors sold 720 Abiomed Inc shares in Q1 2019, an estimated $234K.
  • Kovack Advisors first reported a position in Abiomed Inc in Q1 2018 and held it in 4 quarters.
  • Kovack Advisors's Abiomed Inc position peaked at $440K in Q2 2018.
  • 559 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2019.

Based on Kovack Advisors's 13F filing for Q1 2019, filed 3 May 2019.